ConductScience.org, home

Paper8930655

Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells.

Arienti F and 9 others. Hum Gene Ther, 1996. Cited by 67 papers, by iCite.

Cite this record

ConductScience Library. Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells. Papers, record 8930655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8930655

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells.
PubMed
Journal
Hum Gene Ther
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
1.54
iCite
Revised in PubMed
2012-11-15
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Arienti FF
2Sulé-Suso JJ
3Belli FF
4Mascheroni LL
5Rivoltini LL
6Melani CC
7Maio MM
8Cascinelli NN
9Colombo MPM P
10Parmiani GG

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic TherapyMajor topic
Interleukin-2Major topic
MelanomaMajor topic
Adult
Aged
Antibodies
Antigens, Neoplasm
Cell Line, Transformed
Cell Transplantation
Cytotoxicity Tests, Immunologic
Female
HLA-A2 Antigen
Humans
Isoantigens
Leukocytes, Mononuclear
Male
Middle Aged
Phenotype
Pilot Projects
T-Lymphocytes
T-Lymphocytes, Cytotoxic
Transplantation, Homologous
Tumor Cells, Cultured
Vaccination

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
33669410Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma.Int J Mol Sci2021https://conductscience.org/library/papers/33669410PubMed
24822170Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1.Front Oncol2014https://conductscience.org/library/papers/24822170PubMed
18470726Molecular cancer vaccines: Tumor therapy using antigen-specific immunizations.Pathol Oncol Res1997https://conductscience.org/library/papers/18470726PubMed
17565341Mechanisms of local immunosuppression in cutaneous melanoma.Br J Cancer2007https://conductscience.org/library/papers/17565341PubMed
11896440
Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.
Cancer Gene Ther2002https://conductscience.org/library/papers/11896440PubMed
10516722Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene.Gene Ther1999https://conductscience.org/library/papers/10516722PubMed
10505112Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine.Gene Ther1999https://conductscience.org/library/papers/10505112PubMed
10467372Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.Gene Ther1999https://conductscience.org/library/papers/10467372PubMed
10456655Cancer gene and immunotherapy: recent developments.Med Oncol1999https://conductscience.org/library/papers/10456655PubMed
9392001Recent advances in the treatment of malignant melanoma with gene therapy.Mol Med1997https://conductscience.org/library/papers/9392001PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
PMEL6490PubTator's text mininghttps://conductscience.org/library/genes/6490NCBI Gene
TYR7299PubTator's text mininghttps://conductscience.org/library/genes/7299NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8930655

GET https://conductscience.org/api/papers/v1/8930655/authors